Sorriso Pharmaceuticals, a biopharmaceutical company focused on developing novel oral antibodies for immune-mediated diseases, today announced positive results from its Phase 1b clinical trial of SOR102. This oral, dual-acting biologic…
LimmaTech Biologics AG, a clinical-stage biotech company focused on developing vaccines for life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to…
Vivani Medical, Inc. (Nasdaq: VANI), an innovative biopharmaceutical company specializing in novel, ultra long-acting drug implants, today announced the initiation of screening and enrollment for its first-in-human clinical trial, LIBERATE-1™,…
Palleon Pharmaceuticals, a leader in glyco-immunology drug development for autoimmune diseases and cancer, has announced a collaboration and licensing agreement with Shanghai Henlius Biotech, Inc. (2696.HK). The agreement focuses on…
Insitro, a machine learning-driven drug discovery and development company, announced today that it has received $25 million from Bristol Myers Squibb (NYSE: BMY) following the achievement of discovery milestones and…
Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotech company, announced that five of eight patients have been enrolled in an investigator-initiated academic study of the LD IL-2 + CTLA4-Ig combination…
Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has renewed its long-term partnership with ClinChoice, a contract research organization (CRO). Through…
IKS Health, a provider of care enablement platforms, has partnered with Western Washington Medical Group, a leading multi-specialty healthcare organization in Washington State. This collaboration is designed to help healthcare…
GC Aesthetics® (GCA), a privately-held medical technology company specializing in aesthetic and reconstruction solutions, has announced the launch of an extensive, multi-center, prospective clinical study across Europe. This study aims…
LivaNova PLC (Nasdaq: LIVN), a leading medical technology company, has announced the publication of two pivotal articles in Brain Stimulation journal detailing data from the unipolar cohort of its RECOVER…
Sensorion, a clinical-stage biotechnology company focused on hearing loss therapies, has announced promising safety data from its Phase 1/2 clinical trial, Audiogene, for SENS-501. This gene therapy targets congenital deafness…
MGA Homecare, a prominent provider of home and community-based physical and behavioral health services, has announced its acquisition of Ward Road Pharmacy (WRP), a Long-Term Care Pharmacy (LTCP) and Home…